Initiative For Medicines Access &Knowledge I Mak Inc
Initiative For Medicines Access & Knowledge I Mak Inc shows consistent revenue growth and strong asset accumulation with no reported officer compensation.
EIN: 208559302 · Lewes, DE · NTEE: I83 · Updated: 2026-03-28
Is Initiative For Medicines Access &Knowledge I Mak Inc Legit?
Appears Legitimate
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Initiative For Medicines Access &Knowledge I Mak Inc directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Initiative For Medicines Access &Knowledge I Mak Inc
Initiative For Medicines Access &Knowledge I Mak Inc (EIN: 208559302) is a nonprofit organization based in Lewes, DE, classified under NTEE code I83. The organization reported total revenue of $1.3M and total assets of $4.3M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Initiative For Medicines Access &Knowledge I Mak Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Initiative For Medicines Access &Knowledge I Mak Inc is a mid-size nonprofit that has been operating for 19 years, with 14 years of IRS 990 filings on record (2010–2023). Revenue has grown at a compound annual rate of 24.1%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $2.9M |
| Total Expenses | $1.7M |
| Surplus / Deficit | +$1.3M |
| Total Assets | $4.4M |
| Total Liabilities | $118K |
| Net Assets | $4.3M |
| Operating Margin | 42.8% |
| Debt-to-Asset Ratio | 2.7% |
| Months of Reserves | 31.4 months |
Financial Health Grade: A
In 2023, Initiative For Medicines Access &Knowledge I Mak Inc reported a surplus of $1.3M with revenue exceeding expenses, holds 31.4 months of operating reserves (strong position), has a debt-to-asset ratio of 2.7% (very low leverage).
Financial Trends
Over 14 years of filings (2010–2023), Initiative For Medicines Access &Knowledge I Mak Inc's revenue has grown at a compound annual growth rate (CAGR) of 24.1%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +3.2% | +6.7% | +39.1% |
| 2022 | +52.5% | +14.2% | +71.6% |
| 2021 | +94.6% | +58.8% | +30.8% |
| 2020 | +31.7% | +9.2% | +15.4% |
| 2019 | -22.4% | -69.3% | -24.2% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 2007 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Initiative For Medicines Access &Knowledge I Mak Inc with a Mission Score of 92 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 7%
- programs: 90%
- fundraising: 3%
According to IRS 990 filings, Initiative For Medicines Access &Knowledge I Mak Inc allocates its expenses as follows: admin: 7%, programs: 90%, fundraising: 3%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $1.3M, with revenue exceeding expenses.
- Debt-to-asset ratio: 2.7%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings, suggesting either an entirely volunteer-led executive team or compensation structured in a way that is not reported as officer compensation on the 990, which is highly favorable for donor perception and indicates a strong commitment to directing funds to programs.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Strengths
The following positive indicators were identified for Initiative For Medicines Access &Knowledge I Mak Inc:
- Consistent revenue growth: Revenue increased from $953,611 in 2020 to $2,921,379 in 2023.
- Strong asset growth: Assets grew from $1,400,880 in 2020 to $4,371,767 in 2023.
- Zero reported officer compensation: All filings show 0% officer compensation, indicating high efficiency and program focus.
- Healthy financial reserves: Assets significantly exceed liabilities, with $4,371,767 in assets against $117,875 in liabilities in 2023.
- Positive net income trend: Expenses ($1,670,896 in 2023) are consistently lower than revenue ($2,921,379 in 2023), leading to growth in net assets.
Frequently Asked Questions about Initiative For Medicines Access &Knowledge I Mak Inc
Is Initiative For Medicines Access &Knowledge I Mak Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, Initiative For Medicines Access &Knowledge I Mak Inc (EIN: 208559302) appears legitimate. Mission Score: 92/100. 0 red flags identified, 5 strengths noted.
How does Initiative For Medicines Access &Knowledge I Mak Inc spend its money?
Initiative For Medicines Access &Knowledge I Mak Inc directs 90% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to Initiative For Medicines Access &Knowledge I Mak Inc tax-deductible?
Initiative For Medicines Access &Knowledge I Mak Inc is registered as a tax-exempt nonprofit (EIN: 208559302). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Is Initiative For Medicines Access & Knowledge I Mak Inc a good charity?
Based on its financial data, Initiative For Medicines Access & Knowledge I Mak Inc appears to be a very good charity. It demonstrates strong financial health, consistent revenue growth (from $953,611 in 2020 to $2,921,379 in 2023), and a remarkable commitment to program spending, evidenced by 0% reported officer compensation across all filings.
How has the organization's revenue grown over the past few years?
The organization has shown significant revenue growth, increasing from $953,611 in 2020 to $1,855,914 in 2021, $2,830,909 in 2022, and $2,921,379 in 2023, indicating strong financial support and fundraising efforts.
What is the trend in the organization's assets?
Assets have consistently grown, from $1,400,880 in 2020 to $4,371,767 in 2023, demonstrating a healthy accumulation of resources and financial stability.
Does the organization pay its officers?
According to all available IRS 990 filings, Initiative For Medicines Access & Knowledge I Mak Inc consistently reports 0% officer compensation, suggesting that its officers are either unpaid or compensated through mechanisms not categorized as officer compensation on the 990.
Filing History
IRS 990 filing history for Initiative For Medicines Access &Knowledge I Mak Inc showing financial trends over 14 years of public records:
Over 14 years of IRS 990 filings (2010–2023), Initiative For Medicines Access &Knowledge I Mak Inc's revenue has grown by 1563.4%, moving from $176K to $2.9M. Total assets increased by 1328.9% over the same period, from $306K to $4.4M. Total functional expenses rose by 789.5%, from $188K to $1.7M. In its most recent filing year (2023), Initiative For Medicines Access &Knowledge I Mak Inc reported a surplus of $1.3M, with revenue exceeding expenses. The organization holds $118K in liabilities against $4.4M in assets (debt-to-asset ratio: 2.7%), resulting in net assets of $4.3M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $2.9M | $1.7M | $4.4M | $118K | — | — |
| 2022 | $2.8M | $1.6M | $3.1M | $140K | — | — |
| 2021 | $1.9M | $1.4M | $1.8M | $94K | — | View 990 |
| 2020 | $954K | $863K | $1.4M | $147K | — | — |
| 2019 | $724K | $791K | $1.2M | $50K | — | View 990 |
| 2018 | $933K | $2.6M | $1.6M | $370K | — | View 990 |
| 2017 | $3.7M | $1.9M | $2.7M | $46K | — | View 990 |
| 2016 | $1.1M | $935K | $823K | $49K | — | View 990 |
| 2015 | $675K | $560K | $600K | $15K | — | View 990 |
| 2014 | $404K | $380K | $474K | $4K | — | View 990 |
| 2013 | $328K | $286K | $460K | $15K | — | View 990 |
| 2012 | $275K | $266K | $415K | $13K | — | View 990 |
| 2011 | $303K | $233K | $379K | $6K | — | View 990 |
| 2010 | $176K | $188K | $306K | $3K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $2.9M, expenses of $1.7M, and assets of $4.4M (revenue +3.2% year-over-year).
- 2022: Revenue of $2.8M, expenses of $1.6M, and assets of $3.1M (revenue +52.5% year-over-year).
- 2021: Revenue of $1.9M, expenses of $1.4M, and assets of $1.8M (revenue +94.6% year-over-year).
- 2020: Revenue of $954K, expenses of $863K, and assets of $1.4M (revenue +31.7% year-over-year).
- 2019: Revenue of $724K, expenses of $791K, and assets of $1.2M (revenue -22.4% year-over-year).
- 2018: Revenue of $933K, expenses of $2.6M, and assets of $1.6M (revenue -74.9% year-over-year).
- 2017: Revenue of $3.7M, expenses of $1.9M, and assets of $2.7M (revenue +230.2% year-over-year).
- 2016: Revenue of $1.1M, expenses of $935K, and assets of $823K (revenue +66.4% year-over-year).
- 2015: Revenue of $675K, expenses of $560K, and assets of $600K (revenue +67.0% year-over-year).
- 2014: Revenue of $404K, expenses of $380K, and assets of $474K (revenue +23.2% year-over-year).
- 2013: Revenue of $328K, expenses of $286K, and assets of $460K (revenue +19.3% year-over-year).
- 2012: Revenue of $275K, expenses of $266K, and assets of $415K (revenue -9.1% year-over-year).
- 2011: Revenue of $303K, expenses of $233K, and assets of $379K (revenue +72.4% year-over-year).
- 2010: Revenue of $176K, expenses of $188K, and assets of $306K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Initiative For Medicines Access &Knowledge I Mak Inc:
Data Sources and Methodology
This transparency report for Initiative For Medicines Access &Knowledge I Mak Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.